You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

previously GSK2696273

Showing 1 - 25 of 8,845
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)

Enrolling by invitation
  • Immunologic Deficiency Syndromes
  • Strimvelis
  • Milano, Lombardia, Italy
    Orchard Investigational Site
Jun 23, 2021

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Tumors Trial in Worldwide (Letetresgene autoleucel)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel
  • Pittsburgh, Pennsylvania
  • +5 more
Aug 7, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Lung Cancer, Non-Small Cell Trial in Worldwide (Pembrolizumab, Dostarlimab, GSK4428859A)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • +14 more
Dec 26, 2022

Meningitis, Meningococcal Trial in Worldwide (MenABCWY vaccine, Placebo, MenACWY vaccine)

Active, not recruiting
  • Meningitis, Meningococcal
  • MenABCWY vaccine
  • +3 more
  • Houston, Texas
  • +3 more
Jun 1, 2022

Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

Not yet recruiting
  • Vaccine Reaction
  • COVID-19
  • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
  • VidPrevtyn® Beta vaccine (Sanofi/GSK)
  • Paris, France
    CIC 1417 Cochin-Pasteur
Feb 28, 2023

Asthma Trial (GSK3511294 (Depemokimab))

Not yet recruiting
  • Asthma
  • GSK3511294 (Depemokimab)
  • (no location specified)
Feb 8, 2022

Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200 Gene Therapy)

Active, not recruiting
  • Lysosomal Storage Disease
  • Metachromatic Leukodystrophy
  • OTL-200 Gene Therapy
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 4, 2022

Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)

Active, not recruiting
  • Beta Thalassaemia
  • Safety and Efficacy assessments
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022

Wiskott-Aldrich Syndrome (WAS) Trial in Milan (OTL-103)

Active, not recruiting
  • Wiskott-Aldrich Syndrome (WAS)
  • OTL-103
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Apr 21, 2022

Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Poland (GSK1024805A, Prevenar, Infanrix hexa)

Completed
Has Results
  • Infections, Streptococcal
  • Streptococcus Pneumoniae Vaccines
  • GSK1024805A
  • +4 more
  • Bydgoszcz, Poland
  • +5 more
Jan 11, 2021

Tetanus, Poliomyelitis, Haemophilus Influenzae Type b Trial in Norway, Sweden (Blood Sampling)

Completed
Has Results
  • Tetanus
  • +6 more
  • Blood Sampling
  • Morvik, Norway
  • +3 more
Jan 12, 2021

Immunologic Deficiency Syndromes Trial in Jerusalem, Milano (Gene Therapy, Busulfan, PEG-ADA)

Completed
Has Results
  • Immunologic Deficiency Syndromes
  • Gene Therapy
  • +2 more
  • Jerusalem, Israel
  • +1 more
Jul 15, 2020

Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,

Completed
Has Results
  • Neoplasms, Breast
  • +5 more
  • Tucson, Arizona
  • +103 more
Nov 2, 2021

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Belantamab Mafodotin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 10, 2022

Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200)

Active, not recruiting
  • Lysosomal Storage Disease
  • Metachromatic Leukodystrophy
  • OTL-200
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Sep 29, 2021

Meningococcal Disease, Infections, Meningococcal Trial in Santiago, Bogota, Panama City (MenABCWY+OMV vaccine)

Completed
Has Results
  • Meningococcal Disease
  • Infections, Meningococcal
  • MenABCWY+OMV vaccine
  • Santiago, Chile
  • +6 more
Jun 24, 2020

Immune System Diseases Trial (Strimvelis)

Withdrawn
  • Immune System Diseases
  • Strimvelis
  • (no location specified)
Jul 13, 2020

Malaria Trial in Silver Spring (RTS,S/AS01E (SB257049))

Completed
Has Results
  • Malaria
  • RTS,S/AS01E (SB257049)
  • Silver Spring, Maryland
    GSK Investigational Site
Aug 5, 2020

Tooth Erosion Trial in Indianapolis (0.254% w/w sodium fluoride and 5% KNO3, 0.454% w/w stannous fluoride, 5% KNO3)

Completed
Has Results
  • Tooth Erosion
  • 0.254% w/w sodium fluoride and 5% KNO3
  • +2 more
  • Indianapolis, Indiana
    GSK Investigational Site
Aug 27, 2020

HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

Not yet recruiting
  • HIV
  • HIV Infections
  • (no location specified)
Aug 4, 2023

Infections, Rotavirus, Rotavirus Vaccines Trial in Korea, Republic of (Rotarix ™, Placebo)

Completed
Has Results
  • Infections, Rotavirus
  • Rotavirus Vaccines
  • Rotarix ™
  • Placebo
  • Busan, Korea, Republic of
  • +17 more
Jan 3, 2020

Hepatitis B, Acellular Pertussis, Tetanus Trial in Germany, Poland, Spain (Pneumococcal conjugate vaccine GSK1024850A, Prevenar,

Completed
Has Results
  • Hepatitis B
  • +5 more
  • Pneumococcal conjugate vaccine GSK1024850A
  • +8 more
  • Bad Saulgau, Baden-Wuerttemberg, Germany
  • +62 more
Dec 27, 2019

HIV Trial in Worldwide (Dolutegravir film-coated tablets, Dolutegravir film-coated dispersible tablets, ABC/DTG/3TC immediate

Recruiting
  • HIV Infections
  • Dolutegravir film-coated tablets
  • +3 more
  • Los Angeles, California
  • +16 more
Sep 29, 2022